Latest National University Health System Stories

This discovery may potentially cure patients of multiple myelomaSingapore, Dec 13, 2012 - (ACN Newswire) - Singapore scientists have identified FAIM, a molecule that typically prevents cell death, as a potential biomarker to identify an incurable form of cancer in the bone marrow. Patients with this form of cancer usually do not get cured with current standard treatments such as chemotherapy and stem cell transplantation, with an average survival of only about four...

Singapore, Sept 3, 2012 - (ACN Newswire) - Singapore scientists have identified three new genes associated with Primary Angle Closure Glaucoma (PACG), a leading cause of blindness in Chinese people. PACG affects 15 million people worldwide, 80% of whom live in Asia.The discovery, published in the prestigious scientific journal, Nature Genetics, on 26 August 2012, was conducted collaboratively by scientists from the Singapore Eye Research Institute (SERI)/Singapore National Eye Centre (SNEC),...

JERUSALEM, February 7, 2012 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, announced today that Dr Miriam Kidron, Oramed's Chief Medical and Technology Officer, will be delivering a lecture at the National University Hospital (NUH) in Singapore. The lecture is entitled: "From Discovery to Clinic - New Oral Anti-Diabetes Drug(s)". The lecture will take place on Thursday, February 16, 2012 and is being...

Asian phenotype to be exploredThree Singapore biomedical institutions have launched a major, long-term study of pregnant mothers and their fetuses as well as infant children to determine just how profoundly environmental factors early in life influence the onset of diseases such as obesity and diabetes in later years.The new research program, inspired by research evidence showing that the environment in which a baby is conceived, born and grows up determines the child's growth and...

SINGAPORE, Aug. 15 /PRNewswire-FirstCall/ -- AstraZeneca today announced an innovative new partnership with the National Cancer Centre Singapore (NCCS) and the National University Hospital (NUH) to develop anti-cancer compounds. The collaboration, which is spelt out in a Memorandum of Understanding (MOU) that was signed today, aims to further build AstraZeneca's drug development capabilities in Asia and ultimately speed up access to new medicines of potential benefit to patients with...